Is MaxCyte, Inc. overvalued?

MaxCyte, Inc. (MXCT) — key valuation metrics and fundamentals.

No verdict

Price

$1.16

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$124.3M

Dividend yield

0.0%

Return on equity

-21.0%

Sector

Healthcare

Fair value compares MXCT's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.

Related stocks